Angina (Angina Pectoris)

Angina — more formally angina pectoris, from the Latin for "strangling of the chest" — is the pressure, squeezing, or heaviness you feel when part of the heart muscle is not getting enough oxygen-rich blood. It is not a disease in its own right but a symptom, usually the calling card of narrowed coronary arteries. The reassuring part is that most angina is stable: it follows a predictable pattern, comes on with exertion or stress, eases within a few minutes of rest, and does not, by itself, damage the heart. The dangerous part is that chest pain can also be the first sign of a heart attack — and telling the two apart quickly can save your life. This page explains what angina is, how it feels (including the ways it disguises itself in women and people with diabetes), how it is diagnosed and treated, and — crucially — the red flags that mean you should stop reading and call 911.

What Is Angina?
Types of Angina
Symptoms & How It Feels
Causes & Triggers
Risk Factors
Diagnosis
Treatment
Living With Angina / Self-Management
Prevention
Key Research Papers
Connections

What Is Angina?

Every time the heart beats, its own muscle needs a fresh supply of oxygen delivered through the coronary arteries. Angina happens when that supply falls short of what the muscle is demanding — a state called myocardial ischemia. Think of it as a simple accounting problem between supply and demand.

When you climb stairs, hurry for a bus, or feel a surge of stress, your heart beats faster and harder, and its demand for oxygen rises. In a healthy person the coronary arteries simply widen and deliver more blood. But if a coronary artery is narrowed by atherosclerotic plaque — the fatty, cholesterol-laden buildup of coronary artery disease — the supply is capped. Beyond a certain workload the artery cannot deliver enough blood, the muscle starves for oxygen, and it signals distress as chest discomfort. Rest, and the demand falls back under the ceiling the artery can supply; the pain fades. That predictable, exertion-triggered, rest-relieved pattern is the essence of classic stable angina.

An important distinction runs through everything below: stable angina is a warning, not an injury. The muscle is temporarily short of oxygen, but it recovers when blood flow is restored. A heart attack (myocardial infarction) is different — there, an artery is suddenly and completely blocked, blood flow stops, and heart muscle actually begins to die. Angina is the smoke alarm; a heart attack is the fire.

Types of Angina

Not all angina behaves the same way. The type matters because it changes how urgent the situation is and which treatments work best.

Stable Angina

The most common form. It is predictable: a familiar amount of exertion or emotional stress brings it on, it feels much the same each time, it lasts a few minutes, and it settles with rest or a dose of nitroglycerin. People often learn their own "threshold" — the hill or the flight of stairs that reliably provokes it. Stable angina reflects a fixed narrowing in a coronary artery that becomes limiting only when the heart works hard.

Unstable Angina

A medical emergency and one of the acute coronary syndromes. Unstable angina is angina that is new, worsening (coming more easily, more often, or lasting longer), or occurring at rest. It is caused by a plaque that has cracked or ruptured, triggering a blood clot that suddenly and partly blocks the artery. Because that clot can complete the blockage and cause a heart attack at any moment, unstable angina is treated as an emergency. If your stable pattern suddenly changes, treat it as unstable and seek care immediately.

Variant (Prinzmetal) Angina

Caused not by a fixed plaque but by a sudden spasm of a coronary artery that clamps down and chokes off blood flow. First described by cardiologist Myron Prinzmetal in 1959, variant angina classically strikes at rest, often between midnight and early morning, and may come in cycles. It can occur in arteries that look nearly normal on imaging. Because the mechanism is spasm, calcium channel blockers and nitrates are the mainstays — and beta-blockers, used alone, can sometimes make it worse.

Microvascular Angina

Some people have all the symptoms and objective signs of ischemia, yet their large coronary arteries look open on angiography. The problem lies in the microvasculature — the tiny vessels too small to see, which fail to dilate normally. Once dismissively called "cardiac syndrome X," microvascular angina is now a recognized diagnosis, more common in women, and increasingly identifiable with specialized coronary function testing. It is real ischemia, and it responds to targeted medical therapy.

Symptoms & How It Feels

Classic angina is felt as pressure, tightness, squeezing, or heaviness in the center or left side of the chest — people often describe "an elephant sitting on my chest," a clenched fist, or a tight band. The discomfort may spread to the left arm (or both arms), the shoulders, neck, jaw, upper back, or the pit of the stomach. It is frequently accompanied by shortness of breath, and sometimes by sweating, nausea, lightheadedness, or unusual fatigue.

Two features distinguish typical stable angina from an emergency: it is provoked (by exertion, emotion, cold, or a heavy meal) and it is relieved (by rest or nitroglycerin, usually within about five minutes). Episodes are short. Pain that is fleeting (a split second), pinpoint, easily reproduced by pressing on the chest, or clearly changing with breathing or body position is usually not angina.

How It Differs in Women and People With Diabetes

The "classic" chest-clutching picture was largely drawn from studies of men, and it can mislead. Women more often experience angina as shortness of breath, unusual fatigue, nausea, or discomfort in the jaw, neck, or back — sometimes without prominent chest pressure at all. They are also more likely to have microvascular angina. People with diabetes and older adults may feel blunted or absent pain because of nerve damage (autonomic neuropathy); their ischemia can show up as breathlessness or fatigue — a so-called "anginal equivalent" — or be entirely silent. Atypical does not mean trivial: these presentations carry the same underlying risk and deserve the same evaluation.

When It Means a Heart Attack — Call 911

Call emergency services (911 in the US) right away if chest discomfort:

Is severe, new, or unexpected, or comes on at rest;
Lasts more than a few minutes (roughly 5 or more) or keeps coming back;
Does not ease with rest or after your usual nitroglycerin doses;
Comes with sweating, nausea or vomiting, shortness of breath, lightheadedness or fainting, or a sense of impending doom.

Do not drive yourself — call an ambulance, because treatment can begin on the way. If you have a known heart condition and your care team has advised it, chewing a regular aspirin while you wait can help. Any change in a previously stable pattern — angina that comes more easily, more often, lasts longer, or now appears at rest — is unstable angina and should be treated as an emergency, not shrugged off. When in doubt, make the call. It is far better to be evaluated and sent home than to wait out a heart attack.

Causes & Triggers

The overwhelming majority of angina traces back to coronary artery disease — the slow buildup of atherosclerotic plaque that narrows the arteries feeding the heart. But several other conditions can tip the oxygen supply-and-demand balance toward ischemia:

Coronary artery spasm — the mechanism behind variant angina.
Microvascular dysfunction — disease of the smallest coronary vessels.
Anemia — fewer red cells means blood carries less oxygen to begin with.
Aortic stenosis and hypertrophic cardiomyopathy — a thickened or strained heart muscle needs more oxygen than its arteries can supply.
Fast heart rhythms (see arrhythmias) and severe high blood pressure — both drive up cardiac oxygen demand.
Overactive thyroid and stimulant drugs such as cocaine — which race the heart or provoke spasm.

Within any given person, individual episodes of stable angina are set off by predictable triggers — traditionally remembered as the "four E's": Exertion (physical effort), Emotion (stress, anger, excitement), Eating (a large meal diverts blood to digestion), and Exposure to cold. Smoking and combinations — a brisk walk in cold air after a heavy dinner — are especially provocative.

Risk Factors

Because angina usually reflects underlying coronary artery disease, its risk factors are the familiar cardiovascular ones. Some cannot be changed; most can.

Age and sex — risk rises with age; men are affected earlier, though women's risk climbs after menopause.
Family history of early heart disease.
Smoking and tobacco use — a powerful, modifiable driver of both atherosclerosis and coronary spasm.
High LDL cholesterol and other lipid disorders — see the lipid panel and cholesterol management.
High blood pressure.
Diabetes and insulin resistance.
Obesity, metabolic syndrome, and physical inactivity.
Chronic inflammation and kidney disease, poor diet, and chronic psychological stress.

The more of these that stack up, the higher the risk — and the greater the payoff from addressing them.

Diagnosis

Diagnosing angina is part detective work and part testing. The story — what the discomfort feels like, what brings it on, how long it lasts, what relieves it — is the single most valuable clue, and a good clinician spends real time on it.

Electrocardiogram (ECG/EKG) — a resting tracing is often normal between episodes but may reveal a prior heart attack or capture the tell-tale changes of ischemia if recorded during pain (transient ST-segment shifts; ST elevation during a variant-angina spasm).
Blood tests — troponin to rule out a heart attack when the presentation is acute, plus a lipid panel, blood glucose/HbA1c, a comprehensive metabolic panel, a blood count to check for anemia, and sometimes inflammatory markers such as hs-CRP.
Stress testing — deliberately increasing the heart's workload (walking a treadmill, or with medication if a patient cannot exercise) while watching for ischemia on ECG, on echocardiography (stress echo), or on nuclear perfusion imaging. Stress tests reveal whether a narrowing is functionally limiting blood flow.
Coronary CT angiography (CCTA) — a contrast-enhanced CT scan that pictures the coronary arteries noninvasively. Modern guidelines increasingly favor CCTA as a first-line test for stable chest pain because it can directly show — or confidently rule out — obstructive plaque.
Invasive coronary angiography (cardiac catheterization) — the anatomical gold standard, in which dye is injected through a catheter to map the arteries. It can be combined with a pressure-wire measurement (fractional flow reserve, FFR) to judge whether a specific narrowing truly limits flow, and with coronary function testing (for example, acetylcholine provocation) to diagnose spasm or microvascular angina when the arteries look open.

Treatment

Treatment has two separate goals, and it helps to keep them apart. The first is to relieve symptoms and let you live a fuller life. The second is to prevent heart attacks and death. Some treatments do one, some do the other, and a few do both.

Medications That Relieve Angina

Nitrates. Sublingual nitroglycerin (a tablet or spray under the tongue) is the classic rescue for an acute episode, easing pain within minutes by relaxing veins to lower the heart's workload and by widening coronary arteries. Long-acting nitrates (isosorbide) help prevent episodes but require a daily nitrate-free interval, or the body builds tolerance.
Beta-blockers. By slowing the heart and softening its contractions, they cut oxygen demand. They are a first-line preventive therapy for stable angina and are especially valuable after a heart attack. (They are generally avoided as sole therapy in variant/spasm angina.)
Calcium channel blockers. These relax and widen arteries and reduce demand. They are the treatment of choice for variant/vasospastic angina and a strong option or add-on for stable angina.
Ranolazine. A newer antianginal that works on the heart muscle's metabolism (blocking a "late sodium current") without lowering heart rate or blood pressure — useful as an add-on when other drugs are maxed out or poorly tolerated.

Medications That Prevent Events

Antiplatelet therapy — low-dose aspirin (or an alternative) reduces the risk of clot-driven heart attacks in established coronary disease.
Statins — high-intensity statin therapy lowers LDL cholesterol and, just as importantly, stabilizes plaque so it is less likely to rupture. This is a cornerstone of care.
ACE inhibitors or ARBs — recommended for many patients, particularly those with diabetes, high blood pressure, kidney disease, or reduced heart function.
Risk-factor control — treating blood pressure and diabetes and, above all, stopping smoking.

Revascularization: PCI vs. CABG

When medication is not enough, or when the anatomy is high-risk, blood flow can be physically restored. Percutaneous coronary intervention (PCI) threads a catheter to the narrowing and props the artery open with a stent — no surgery, quick recovery. Coronary artery bypass grafting (CABG) is open-heart surgery that reroutes blood around blockages using graft vessels; it tends to win out for complex multi-vessel disease, left-main disease, and many people with diabetes.

The "Medications First" Story for Stable Disease

For decades it seemed obvious that opening a narrowed artery in someone with stable angina must prevent heart attacks. A remarkable run of clinical trials showed that, for stable disease, the truth is more nuanced — and this evidence directly shapes today's guidelines.

COURAGE (2007) found that adding PCI to good medical therapy did not reduce death or heart attack compared with medical therapy alone in stable coronary disease. PCI relieved symptoms sooner, but that edge narrowed over the following years.
FAME 2 (2012) refined the picture: guiding PCI by FFR (treating only narrowings proven to limit flow) reduced the need for urgent later procedures, though again without cutting death or heart attack.
ORBITA (2018), the first trial to compare PCI against a placebo (sham) procedure, found that in stable single-vessel angina already on medication, stenting improved exercise time no more than a convincingly faked procedure — a startling reminder of how much expectation shapes symptoms.
ISCHEMIA (2020), the largest such trial, showed that in stable patients with moderate-to-severe ischemia, an initial invasive strategy did not reduce cardiovascular events over several years versus a conservative, medications-first strategy — though it did improve angina-related quality of life for those who had frequent symptoms.
ORBITA-2 (2023) added the other half of the story: in patients on little or no antianginal medication, PCI did reduce angina and improve exercise capacity versus a placebo procedure — so stenting genuinely relieves symptoms, especially in people not already medicated.

The bottom line that guidelines draw from all this: for stable/chronic coronary disease, optimal medical therapy is the foundation, and revascularization is added mainly to relieve symptoms that medications cannot control, or for specific high-risk anatomy — not as a reflex to "fix" every narrowing. (This calculus is entirely different for unstable angina and heart attack, where prompt, often urgent revascularization saves lives.)

Living With Angina / Self-Management

For most people, angina is a manageable long-term condition, not a sentence. Living well with it comes down to a handful of habits.

Know your pattern and your rescue plan. Carry nitroglycerin, keep it fresh, and know how to use it: stop and sit down, take a dose, and if the discomfort has not eased after the number of doses and the time your clinician specified, call 911. Learn the difference between "my usual angina" and a red-flag change.
Do cardiac rehabilitation. A supervised program of graded exercise, education, and support measurably improves symptoms, fitness, confidence, and outcomes. It is one of the most underused effective therapies in cardiology.
Take your preventive medicines every day — the statin and aspirin work quietly in the background even when you feel fine.
Pace yourself and pre-empt triggers — warm up before effort, avoid heavy meals right before exertion, dress for the cold, and manage stress. Anxiety and depression are common with heart disease and can worsen symptoms, so treat them too.
A safety note on medications: nitrates must never be combined with erectile-dysfunction drugs such as sildenafil — the pair can cause a dangerous drop in blood pressure. Always tell every prescriber you take nitrates.

Many people also ask about diet and supplements. A heart-protective eating pattern — the Mediterranean diet is the best-studied — genuinely lowers cardiovascular risk. Certain nutrients and botanicals are sometimes discussed as adjuncts, including Coenzyme Q10 (of interest with statin-related muscle aches), magnesium, hawthorn, garlic, L-arginine, L-carnitine, and taurine. The evidence for these in angina ranges from modest to inconclusive, and several interact with heart medications — they are complements to proven therapy, never substitutes for it. Talk to your cardiologist before adding anything.

Prevention

Because angina is usually the voice of coronary artery disease, preventing it means preventing — and slowing — atherosclerosis. The levers are well established and mutually reinforcing:

Do not smoke, and avoid secondhand smoke. This single step lowers risk more than almost anything else.
Eat a heart-protective diet — a Mediterranean-style pattern rich in vegetables, fruit, legumes, whole grains, nuts, olive oil, and fish.
Move regularly — aim for the widely recommended 150 minutes a week of moderate aerobic activity, building up gradually and safely.
Keep the numbers in range — blood pressure, LDL cholesterol, and blood sugar, with medication when lifestyle alone is not enough.
Maintain a healthy weight and address metabolic syndrome.
Manage stress and sleep, and stay connected to regular medical care so risks are caught early.

The same measures that prevent angina also help everyone who already has it — there is no age or stage at which they stop paying off.

Key Research Papers

Virani SS, Newby LK, Arnold SV, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease. Circulation. 2023;148(9):e9-e119.
Knuuti J, Wijns W, Saraste A, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. European Heart Journal. 2020;41(3):407-477.
Ohman EM. Chronic stable angina. New England Journal of Medicine. 2016;374(12):1167-1176.
Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease (COURAGE). New England Journal of Medicine. 2007;356(15):1503-1516.
De Bruyne B, Pijls NHJ, Kalesan B, et al. Fractional flow reserve–guided PCI versus medical therapy in stable coronary disease (FAME 2). New England Journal of Medicine. 2012;367(11):991-1001.
Al-Lamee R, Thompson D, Dehbi HM, et al. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. The Lancet. 2018;391(10115):31-40.
Maron DJ, Hochman JS, Reynolds HR, et al. Initial invasive or conservative strategy for stable coronary disease (ISCHEMIA). New England Journal of Medicine. 2020;382(15):1395-1407.
Spertus JA, Jones PG, Maron DJ, et al. Health-status outcomes with invasive or conservative care in coronary disease (ISCHEMIA quality-of-life). New England Journal of Medicine. 2020;382(15):1408-1419.
Rajkumar CA, Foley MJ, Ahmed-Jushuf F, et al. A placebo-controlled trial of percutaneous coronary intervention for stable angina (ORBITA-2). New England Journal of Medicine. 2023;389(25):2319-2330.
Ford TJ, Stanley B, Good R, et al. Stratified medical therapy using invasive coronary function testing in angina (CorMicA). Journal of the American College of Cardiology. 2018;72(23):2841-2855.
Chaitman BR, et al. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina (CARISA). JAMA. 2004;291(3):309-316.
Morrow DA, et al. Effects of ranolazine on recurrent cardiovascular events in patients with non–ST-elevation acute coronary syndromes (MERLIN-TIMI 36). JAMA. 2007;297(16):1775-1783.

↑ Back to Table of Contents

Live PubMed Searches

These links open live PubMed searches — results refresh as new studies are indexed.

↑ Back to Table of Contents

Connections

↑ Back to Table of Contents